Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink

BMJ (2016) - Comment
pubmed: 27659058 doi: 10.1136/bmj.i4823 issn: 1756-1833

Katrina Wilcox Hagberg, Hozefa A Divan, Rebecca Persson, J Curtis Nickel, Susan S Jick